Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise. - Wikidata - wikimedia - TriplyDB

Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.

Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.

http://www.wikidata.org/entity/Q36764607

about

The renin-angiotensin system and prevention of age-related functional decline: where are we now?Role of circulating factors in cardiac aging.Do ACE inhibitors improve the response to exercise training in functionally impaired older adults? A randomized controlled trial Optimizing the benefits of exercise on physical function in older adults.Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.Multi-modal intervention to reduce cardiovascular risk among hypertensive older adults: Design of a randomized clinical trial.Successful aging: Advancing the science of physical independence in older adults.Effects of a One-Year Physical Activity Program on Serum C-Terminal Agrin Fragment (CAF) Concentrations among Mobility-Limited Older Adults.Hypertension and aging.Toward exercise as personalized medicine.Antihypertensive Use and the Effect of a Physical Activity Intervention in the Prevention of Major Mobility Disability Among Older Adults: The LIFE Study.Genetic influence on exercise-induced changes in physical function among mobility-limited older adults.Predictors of Change in Physical Function in Older Adults in Response to Long-Term, Structured Physical Activity: The LIFE Study.Sleep/wake patterns and physical performance in older adults.Antihypertensive monotherapy or combined therapy: which is more effective on functional status?Resveratrol and exercise to treat functional limitations in late life: design of a randomized controlled trial.

P2860

Q28085528-3DF1BA95-F05A-47B3-BABE-B893BBE24E58 Q30234641-D57AB59F-424B-43BB-ABBE-337A3D38E4EC Q33615993-B92B341D-2CF4-4C6C-A67C-207AAE08F0F0 Q33779905-67AE2053-852C-4214-80EB-4E9500C4ADC5 Q35749354-9479E584-6311-4012-8247-A8F57D764260 Q35908858-80E6B7E9-10A4-455B-BBB1-DFEC70E6C925 Q36322590-103ED34D-FBEE-4028-B0A9-610A636D64B7 Q36380725-AE6C572D-6CC3-4EA9-B16A-7BA72320B300 Q36623143-136AE8BF-6665-44EE-B9FD-D53B67C7819D Q36678544-C3F9C9EB-F914-4AD1-889B-2E3AD21572CB Q37000459-1C1BA7BB-0C6D-4FDA-AFB9-F6FB5DA6250A Q37629357-0C99A1B4-205C-43CE-B4C3-9C6559FFB235 Q40604606-3ACE85EB-78D0-4176-98F0-702A9C4341B6 Q48173369-176E547B-C575-4D6A-A070-CC8CB406EE9E Q48237130-D152D9E1-64BE-45FC-8D96-25ACD9A7DBAE Q53060494-4DF9B0F2-67EA-4B83-890B-40089DFD9865

P2860

Angiotensin-converting enzyme inhibitor use by older adults is associated with greater functional responses to exercise.

http://www.wikidata.org/entity/Q36764607

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Angiotensin-converting enzyme ...... ctional responses to exercise.

@ast

Angiotensin-converting enzyme ...... ctional responses to exercise.

@en

type

label

Angiotensin-converting enzyme ...... ctional responses to exercise.

@ast

Angiotensin-converting enzyme ...... ctional responses to exercise.

@en

prefLabel

Angiotensin-converting enzyme ...... ctional responses to exercise.

@ast

Angiotensin-converting enzyme ...... ctional responses to exercise.

@en

P1433

Q36764607-5310C059-CFF5-42EB-A171-3138ADD6E2AF

P1476

Q36764607-90544A10-4F76-4E34-B67D-77B079A0A4C2

P2093

Q36764607-04241152-3945-48CF-B5A2-A37A506ACF7E

Q36764607-490B54DF-9832-4EF8-B425-12E65C97910C

Q36764607-4C6DB1B8-1D8A-4E17-AD28-DE2F6AC2B4BA

Q36764607-80026591-2F5A-4F64-953D-2754B29452F3

Q36764607-81D71A50-07B7-4DD1-8EA2-661D5D36FEAB

Q36764607-A0A18686-A062-4284-AD9A-2F1F3C8CBF10

Q36764607-AD6C8195-9CA2-47D5-AD03-8418464BAA53

Q36764607-CCE4C084-C355-4813-8E48-65F63ACD8806

Q36764607-DF76EB44-4B36-4542-BEAF-9A5AB747162C

Q36764607-FC6B2B72-25F7-44DF-81E2-D478208BEB42

P2860

Q36764607-1AF2B5A7-FB99-4872-A063-AAC6E5FFC554

Q36764607-23552C56-D3D6-4E77-A8CD-6BB1EF9950A4

Q36764607-2427F4DE-3214-4732-874E-7FDA507F1849

Q36764607-26CCE00E-62DF-4D49-B314-DC1B2002484E

Q36764607-30F36672-76AC-48DA-BD39-B74212CD7B85

Q36764607-36A9D1A3-E026-47FC-9CDA-115B41955167

Q36764607-398A84AB-E0BD-4579-998A-94DA42D3B420

Q36764607-3BD17007-5858-470C-9E30-76D86E488F65

Q36764607-43F87254-008F-4D6B-A855-DF15E5EF0568

Q36764607-57FD36F1-19D8-4AE6-BB61-D98425657AED

P304

Q36764607-3A3E1D96-B6FC-482E-87AC-508863725AC3

P31

Q36764607-A2C13F18-7CB3-4116-9882-4C367D3691F2

P356

Q36764607-E52A62A7-9F87-4A5B-9EDA-E7507F1E307A

P407

Q36764607-5A5CC02E-3723-4205-B000-FD1399667698

P433

Q36764607-322A3990-661F-482E-9ACA-6D656FE70296

P478

Q36764607-E3D366E3-08A7-458D-91E4-3052526D6E9D

P577

Q36764607-9A859BA6-E67F-4C9A-8C42-F242977BC7C1

P5875

Q36764607-CE6525A3-E0EE-4997-AB9A-FCE2693E2A4B

P698

Q36764607-AAA7EBCF-F61F-450F-8F68-F378061517C1

P932

Q36764607-CF24F1DC-AFC0-4CB1-9998-EFC46E9E5E27

P356

J.1532-5415.2012.04045.X

P1433

Journal of the American Geriatrics Society

P1476

Angiotensin-converting enzyme ...... ctional responses to exercise.

@en

P2093

Christy S Carter

http://www.w3.org/2001/XMLSchema#string

Fang-Chi Hsu

http://www.w3.org/2001/XMLSchema#string

Marco Pahor

http://www.w3.org/2001/XMLSchema#string

Matteo Cesari

http://www.w3.org/2001/XMLSchema#string

Randall S Stafford

http://www.w3.org/2001/XMLSchema#string

Stephen D Anton

http://www.w3.org/2001/XMLSchema#string

Susan Nayfield

http://www.w3.org/2001/XMLSchema#string

Thomas W Buford

http://www.w3.org/2001/XMLSchema#string

Timothy S Church

http://www.w3.org/2001/XMLSchema#string

Todd M Manini

http://www.w3.org/2001/XMLSchema#string

P2860

AMPK and PPARdelta agonists are exercise mimetics

Association between concurrent and remote blood pressure and disability in older adults.

Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Risk factors for disability in older persons over 3-year follow-up.

ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.

ACE genotype and the muscle hypertrophic and strength responses to strength training

Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training.

Methods to explain the clinical significance of health status measures.

Gait speed and survival in older adults.

What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study)

P304

1244-1252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1532-5415.2012.04045.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228060146

http://www.w3.org/2001/XMLSchema#string

P698

22726232

http://www.w3.org/2001/XMLSchema#string

P932

3625953

http://www.w3.org/2001/XMLSchema#string